Online inquiry

IVTScrip™ mRNA-Human ASB15, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK26896MR)

This product GTTS-WK26896MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ASB15 protein. This product can be used in B cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001290258.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 142685
UniProt ID Q8WXK1
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ASB15, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK26896MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK19223MR IVTScrip™ mRNA-Human AHNAK2, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AHNAK2
GTTS-WK16060MR IVTScrip™ mRNA-Human AMPH, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA AMPH
GTTS-WK23263MR IVTScrip™ mRNA-Human ARNTL, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARNTL
GTTS-WK14061MR IVTScrip™ mRNA-Human ADORA2B, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ADORA2B
GTTS-WK21209MR IVTScrip™ mRNA-Human ANKRD20A8P, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ANKRD20A8P
GTTS-WK9207MR IVTScrip™ mRNA-Human ADAMTS9, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ADAMTS9
GTTS-WK1519MR IVTScrip™ mRNA-Human RUNX2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA RUNX2
GTTS-WK20342MR IVTScrip™ mRNA-Human ANKZF1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANKZF1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →